Genetics of Interleukin 1 Receptor-Like 1 in Immune [47] [48] [49] [50] [51] [52] [53] [54] [55] [56] [57] [58] Gudbjartsson, D. F.; Bjornsdottir, U. S.; Halapi, E.; Helgadottir, A.; Sulem, P.; Jonsdottir, G. M.; Thorleifsson, G.; Helgadottir, H.; Ste- inthorsdottir, V.; Stefansson, H.; Williams, C.; Hui, J.; Beilby, J.; Warrington, N. M.; James, A.; Palmer, L. J.; Koppelman, G. H.; Heinzmann, A.; Krueger, M.; Boezen, H. M.; Wheatley, A.; Alt- muller, J.; Shin, H. D.; Uh, S.-T.; Cheong, H. S.; Jonsdottir, B.; Gislason, D.; Park, C.-S.; Rasmussen, L. M.; Porsbjerg, C.; Han- sen, J. W.; Backer, V.; Werge, T.; Janson, C.; Jonsson, U.-B.; Ng, M. C. Y.; Chan, J.; So, W. Y.; Ma, R.; Shah, S. H.; Granger, C. B.; Quyyumi, A. A.; Levey, A. I.; Vaccarino, V.; Reilly, M. P.; Rader, D. J.; Williams, M. J. A.; van Rij, A. M.; Jones, G. T.; Trabetti, E.; Malerba, G.; Pignatti, P. F.; Boner, A.; Pescollderungg, L.; Girelli, D.; Olivieri, O.; Martinelli, N.; Ludviksson, B. R.; Ludviksdottir, D.; Eyjolfsson, G. I.; Arnar, D.; Thorgeirsson, G.; Deichmann, K.; Thompson, P. J.; Wjst, M.; Hall, I. P.; Postma, D. S.; Gislason, T.; Gulcher, J.; Kong, A.; Jonsdottir, I.; Thorsteinsdottir, U.; Stefans- son, K. Sequence variants affecting eosinophil numbers associate with asthma and myocardial infarction. Nat. Genet., 2009, 41(3), 342-347. Buysschaert, I. D.; Grulois, V.; Eloy, P.; Jorissen, M.; Rombaux, P.; Bertrand, B.; Collet, S.; Bobic, S.; Vlaminck, S.; Hellings, P. W.; Lambrechts, D. Genetic evidence for a role of IL33 in nasal polyposis. Allergy, 2009, 65(5), 616-622. Wu, H.; Romieu, I.; Shi, M.; Hancock, D. B.; Li, H.; Sienra- Monge, J.-J.; Chiu, G. Y.; Xu, H.; del Rio-Navarro, B. E.; London, S. J. Evaluation of candidate genes in a genome-wide association study of childhood asthma in Mexicans. J. Allergy Clin. Immunol., 2009, 125(2), 321-327.e13. Kato, A.; Schleimer, R. P. Beyond inflammation: airway epithelial cells are at the interface of innate and adaptive immunity. Curr. Opin. Immunol., 2007, 19(6), 711-720. Mangan, Niamh E.; Dasvarma, A.; McKenzie, Andrew N.; Padraic , G. F. T1/ST2 expression on Th2 cells negatively regulates allergic pulmonary inflammation. Eur. J. Immunol., 2007, 37(5), 1302-1312. Hacker, S.; Lambers, C.; Pollreisz, A.; Hoetzenecker, K.; Lichten- auer, M.; Mangold, A.; Niederpold, T.; Hacker, A.; Lang, G.; Dworschak, M.; Vukovich, T.; Gerner, C.; Klepetko, W.; Anker- smit, H. Increased soluble serum markers caspase-cleaved cy- tokeratin-18, histones, and ST2 indicate apoptotic turnover and chronic immune response in COPD. J. Clin. Lab. Anal., 2009, 23(6), 372-379. Shimizu, M.; Matsuda, A.; Yanagisawa, K.; Hirota, T.; Akahoshi, M.; Inomata, N.; Ebe, K.; Tanaka, K.; Sugiura, H.; Nakashima, K.; Tamari, M.; Takahashi, N.; Obara, K.; Enomoto, T.; Okayama, Y.; Gao, P.-S.; Huang, S.-K.; Tominaga, S.-i.; Ikezawa, Z.; Shirakawa, T. Functional SNPs in the distal promoter of the ST2 gene are associated with atopic dermatitis. Hum. Mol. Genet., 2005, 14(19), 2919-2927. Sakashita, M.; Yoshimoto, T.; Hirota, T.; Harada, M.; Okubo, K.; Osawa, Y.; Fujieda, S.; Nakamura, Y.; Yasuda, K.; Nakanishi, K.; Tamari, M. Association of serum interleukin-33 level and the inter- leukin-33 genetic variant with Japanese cedar pollinosis. Clin. Exp. Allergy, 2008, 38(12), 1875-1881. Castano, R.; Bossé, Y.; Endam, L. M.; Desrosiers, M. Evidence of association of interleukin-1 receptor-like 1 gene polymorphisms with chronic rhinosinusitis. Am. J. Rhinol. Allergy, 2009, 23, 377- 384. Kuroiwa, K.; Arai, T.; Okazaki, H.; Minota, S.; Tominaga, S.-i. Identification of Human ST2 Protein in the Sera of Patients with Autoimmune Diseases. Biochem. Biophys. Res. Commun., 2001, 284(5), 1104-1108. Mok, M. Y.; Huang, F. P.; Ip, W. K.; Lo, Y.; Wong, F. Y.; Chan, E. Y. T.; Lam, K. F.; Xu, D. Serum levels of IL-33 and soluble ST2 and their association with disease activity in systemic lupus erythematosus. Rheumatology, 2010, 49(3), 520-527. Han, J. W.; Zheng, H. F.; Cui, Y.; Sun, L. D.; Ye, D. Q.; Hu, Z.; Xu, J. H.; Cai, Z. M.; Huang, W.; Zhao, G. P.; Xie, H. F.; Fang, H.; Lu, Q. J.; Xu, J. H.; Li, X. P.; Pan, Y. F.; Deng, D. Q.; Zeng, F. Q.; Ye, Z. Z.; Zhang, X. Y.; Wang, Q. W.; Hao, F.; Ma, L.; Zuo, X. B.; Zhou, F. S.; Du, W. H.; Cheng, Y. L.; Yang, J. Q.; Shen, S. K.; Li, J.; Sheng, Y. J.; Zuo, X. X.; Zhu, W. F.; Gao, F.; Zhang, P. L.; Guo, Q.; Li, B.; Gao, M.; Xiao, F. L.; Quan, C.; Zhang, C.; Zhang, Z.; Zhu, K. J.; Li, Y.; Hu, D. Y.; Lu, W. S.; Huang, J. L.; Liu, S. X.; Li, H.; Ren, Y. Q.; Wang, Z. X.; Yang, C. J.; Wang, P. G.; Zhou, W. M.; Lv, Y. M.; Zhang, A. P.; Zhang, S. Q.; Lin, D.; Li, [59] [60] [61] [62] [63] [64] [65] [66] [67] [68] [69] [70] [71] [72] Current Genomics, 2010, Vol. 11, No. 8 605 Y.; Low, H. Q.; Shen, M.; Zhai, Z. F.; Wang, Y.; Zhang, F. Y.; Yang, S.; Liu, J. J.; Zhang, X. J. Genome-wide association study in a Chinese Han population identifies nine new susceptibility loci for systemic lupus erythematosus. Nat. Genet., 2009, 41(11), 1234-7. Graham, R. R.; Hom, G.; Ortmann, W.; Behrens, T. W. Review of recent genome-wide association scans in lupus. J. Intern. Med., 2009, 265(6), 680-8. Leung, B. P.; Xu, D.; Culshaw, S.; McInnes, I. B.; Liew, F. Y. A Novel therapy of murine collagen-induced arthritis with soluble T1/ST2. J. Immunol., 2004, 173(1), 145-150. Palmer, G.; Talabot-Ayer, D.; Lamacchia, C.; Toy, D.; Seemayer, C. A.; Viatte, S.; Finckh, A.; Smith, D. E.; Gabay, C. Inhibition of interleukin-33 signaling attenuates the severity of experimental ar- thritis. Arthritis Rheum., 2009, 60(3), 738-749. Matsuyama, Y.; Okazaki, H.; Tamemoto, H.; Kimura, H.; Kamata, Y.; Nagatani, K.; Nagashima, T.; Hayakawa, M.; Iwamoto, M.; Yoshio, T.; Tominaga, S.; Minota, S. Increased levels of interleu- kin 33 in sera and synovial fluid from patients with active rheuma- toid arthritis. J. Rheumatol., 2010, 37(1), 18-25. Xu, D.; Jiang, H.-R.; Li, Y.; Pushparaj, P. N.; Kurowska-Stolarska, M.; Leung, B. P.; Mu, R.; Tay, H. K.; McKenzie, A. N. J.; McIn- nes, I. B.; Melendez, A. J.; Liew, F. Y. IL-33 exacerbates autoanti- body-induced arthritis. J. Immunol., 2010, 184(5), 2620-2626. Orozco, G.; Barton, A. Update on the genetic risk factors for rheu- matoid arthritis. Expert. Rev. Clin. Immunol., 2010, 6(1), 61-75. Beltrán, C. J.; Núñez, L. E.; Díaz-Jiménez, D.; Farfan, N.; Candia, E.; Heine, C.; López, F.; González, M. J.; Quera, R.; Hermoso, M. A. Characterization of the novel ST2/IL-33 system in patients with inflammatory bowel disease. Inflamm. Bowel Dis., 2009, Epub ahead of print. Pastorelli, L.; Garg, R. R.; Hoang, S. B.; Spina, L.; Mattioli, B.; Scarpa, M.; Fiocchi, C.; Vecchi, M.; Pizarro, T. T. Epithelial- derived IL-33 and its receptor ST2 are dysregulated in ulcerative colitis and in experimental Th1/Th2 driven enteritis. Proc. Natl. Acad. Sci. USA, 2010, 107(17), 8017-8022. Zhernakova, A.; Festen, E.; Franke, L.; Trynka, G.; Van Diemen, C.; Monsuur, A.; Bevova, M.; Nijmeijer, R.; Van 't Slot, R.; Hei- jmans, R.; Boezen, H.; Van Heel, D.; Van Bodegraven, A.; Stok- kers, P.; Wijmenga, C.; Crusius, J.; RK, W. Genetic analysis of in- nate immunity in Crohn's disease and ulcerative colitis identifies two susceptibility loci harboring CARD9 and IL18RAP. Am. J. Hum. Genet., 2008, 82(5), 1202-10. Van Heel, D. A.; Franke, L.; Hunt, K. A.; Gwilliam, R., Alexandra; Inouye, M.; Wapenaar, M. C.; Barnardo, M. C. N. M.; Bethel, G.; Holmes, G. K. T.; Feighery, C.; Jewell, D.; Kelleher, D.; Kumar, P.; Travis, S.; Walters, J. R. F.; Sanders, D. S.; Howdle, P.; Swift, J.; Playford, R. J.; McLaren, W. M.; Mearin, M. L.; Mulder, C. J.; McManus, R.; McGinnis, R.; Cardon, L. R.; Deloukas, P.; Wi- jmenga, C. A genome-wide association study for celiac disease identifies risk variants in the region harboring IL2 and IL21. Nat. Genet., 2007, 39(7), 827-829. Imielinski, M.; Baldassano, R. N.; Griffiths, A.; Russell, R. K.; Annese, V.; Dubinsky, M.; Kugathasan, S.; Bradfield, J. P.; Wal- ters, T. D.; Sleiman, P.; Kim, C. E.; Muise, A.; Wang, K.; Glessner, J. T.; Saeed, S.; Zhang, H.; Frackelton, E. C.; Hou, C.; Flory, J. H.; Otieno, G.; Chiavacci, R. M.; Grundmeier, R.; Castro, M.; Latiano, A.; Dallapiccola, B.; Stempak, J.; Abrams, D. J.; Taylor, K.; McGovern, D.; Heyman, M. B.; Ferry, G. D.; Kirschner, B.; Lee, J.; Essers, J.; Grand, R.; Stephens, M.; Levine, A.; Piccoli, D.; Van Limbergen, J.; Cucchiara, S.; Monos, D. S.; Guthery, S. L.; Den- son, L.; Wilson, D. C.; Grant, S. F. A.; Daly, M.; Silverberg, M. S.; Satsangi, J.; Hakonarson, H. Common variants at five new loci as- sociated with early-onset inflammatory bowel disease. Nat. Genet., 2009, 41(12), 1335-1340. Mensah-Brown, E.; Shahin, A.; Parekh K, H. A., Shamisi MA, Hsu DK; Lukic, M. Functional capacity of macrophages determines the induction of type 1 diabetes. Ann. N. Y. Acad. Sci., 2006, 1084, 49- 57. Elbein, S. C.; Das, S. K.; Hallman, D. M.; Hanis, C. L.; Hasstedt, S. J. Genome-wide linkage and admixture mapping of type 2 diabe- tes in African American families from the American Diabetes As- sociation GENNID (Genetics of NIDDM) Study Cohort. Diabetes, 2009, 58(1), 268-74. Seki, K.; Sanada, S.; Kudinova, A. Y.; Steinhauser, M. L.; Handa, V.; Gannon; Joseph; Lee, R. T. Interleukin-33 prevents apoptosis